Onderneming Nemus Bioscience Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 19-01-18 |
Director of Finance/CFO | - | 05-10-21 | |
Chief Tech/Sci/R&D Officer | 52 | 13-12-22 | |
Karam Takhar
IRC | Investor Relations Contact | - | - |
Rhea Williams
LAW | General Counsel | - | 07-10-21 |
Thomas S. Kim
LAW | General Counsel | - | - |
Tu Diep
PRN | Corporate Officer/Principal | 43 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 07-08-20 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 22-07-21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 18-08-23 |
Paul Grayson
BRD | Director/Board Member | - | 18-08-23 |
Punit Dhillon
CEO | Chief Executive Officer | 44 | 19-01-18 |
Keith Ward
BRD | Director/Board Member | 54 | 14-12-21 |
Deborah Charych
BRD | Director/Board Member | - | 14-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 28 067 907 | 26 079 747 ( 92,92 %) | 0 | 92,92 % |
Bedrijfsgegevens
![Adres Nemus Bioscience Inc](https://cdn.zonebourse.com/static/address/19156979.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+35,79% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |